Progressive liver impairment as a predictor of reduced survival in individuals with EGFR-mutated non-small cell lung cancer and liver metastases undergoing treatment with EGFR tyrosine kinase inhibitors - Quiz - MDSpire

Progressive liver impairment as a predictor of reduced survival in individuals with EGFR-mutated non-small cell lung cancer and liver metastases undergoing treatment with EGFR tyrosine kinase inhibitors

  • By

  • Wen Zhang

  • Xuemei Wu

  • Xiaorong Sun

  • Jian Wen

  • Xiaoli He

  • Mingzhou Zhang

  • Guansong Wang

  • Zhi Xu

  • January 23, 2026

  • 0 min

Share

Original Source(s)

Progressive liver impairment as a predictor of reduced survival in individuals with EGFR-mutated non-small cell lung cancer and liver metastases undergoing treatment with EGFR tyrosine kinase inhibitors

  • by Wen Zhang, Xuemei Wu, Xiaorong Sun, Jian Wen, Xiaoli He, Mingzhou Zhang, Guansong Wang, Zhi Xu

  • January 23, 2026

Related Content

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment

Potential targets for boron transport in boron neutron capture therapy

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation